Republicans have been vowing for six years now to repeal the Affordable Care Act. A Donald Trump victory could do just that.
The Need To Replace EpiPens Regularly Adds To Concerns About Cost
The EpiPen expires once a year yet when tested the drug can be effective much longer. You will be surprised how Americans get ripped off legally.
Remember The ‘Public Option’? Insurance Commissioner Wants To Try It In California
California’s insurance commissioner said he supports a public option at the state level that could bolster competition and serve as a nationwide test.
EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog
Consumers and Congress members pushing for cheaper alternatives to the EpiPen and other high-priced drugs are seeking answers about a stubborn backlog.
Getting Doctor Lists Right
Outdated doctor lists can inadvertently put patients into out-of-network care which could be very expensive. Here are your recourses.
How To Fight For Yourself At The Hospital — And Avoid Readmission
When hospitals readmit aging patients more often than average, they can face stiff government penalties. Readmissions are costly.
Burwell Says HHS Trying To Bring More Insurers Into Marketplaces
Federal officials continue to make operational adjustments in the health law marketplaces and meet with some insurers to encourage them to offer more plans.
Drop In Teen Pregnancies Is Due To More Contraceptives, Not Less Sex
From 2007 to 2013, births to teens age 15 to 19 dropped by 36 percent; pregnancies fell by 25 percent from 2007 to 2011 and here is why.
‘Simple Choice Plans’ To Debut In 2017 Marketplace Enrollment
Despite much hand-wringing about health insurers exiting the marketplaces where people buy individual coverage, Simple Choice Plans to the rescue?
Mylan’s Generic EpiPen — A Price Break Or Marketing Maneuver?
Mylan’s new maneuver to play around with EpiPen pricing is a perfect illustration of the fraud that is our health care system. We need Medicare for all.